Tandem Diabetes (TNDM) Tops Q4 EPS by 11c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results
February 24, 2016 4:05 PM ESTSAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:flex® and t:slim G4 Insulin Pumps, today reported its financial results for the quarter and year ended December 31, 2015.
In comparing the fourth quarter of 2015 to the same period of 2014:
Sales grew 63 percent to $29.1 million from $17.9 million Pump shipments grew 59 percent to 6,234 pumps from 3,929 pumps Operating margin improved to negative 39 percent from negative 98 percentIn comparing the year ended December 31, 2015 to the same... More
